EUVIMEDEUVIMED entdecken
Crossref

The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐ Helicobacter pylori treatment in real‐world clinical practice

Chun-Te Lee iD, Chung-Tai Wu, Wei-Lun Chang iD, Er-Hsiang Yang, Ming-Tsung Hsieh, Wei-Ying Chen, Bor-Shyang Sheu iD, Hsiu-Chi Cheng iD

Helicobacter · 2024-01 · 29 (1)

DOI: 10.1111/hel.13033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, online erschienen am 10.11.2023. Verfasst von Chun-Te Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministry of Health and Welfare, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The eradication rates of sequential therapy are high in clinical trials; however, the adherence for follow‐up or the patient population in a real‐world setting might be different from those in trails. This study investigates the effectiveness of sequential therapy in a real‐world setting and the factors that lead to treatment failure. Materials and Methods In this retrospective study, patients receiving sequential therapy as a first‐line anti‐ Helicobacter pylori ( H. pylori ) treatment in a real‐world setting were reviewed. The age adjusted Charlson Comorbidity Index (age‐CCI) and baseline variety of medications were reviewed to determine factors correlated with nonadherence for post‐treatment testing and H. pylori eradication failure.

Results

A total of 1053 patients were reviewed. A total of 579 patients receiving sequential therapy were included in the analyses. Among them, 462 received post‐treatment testing and were placed into the follow‐up group. Thus, the post‐treatment testing rate was 79.8%. Stroke was an independent factor of nonadherence for post‐treatment testing. In the follow‐up group, the eradication failure rate was 8.2%. Female sex (odds ratio [OR] 2.41 [95% CI 1.16–5.03], p = 0.02) and age‐CCI ≥2 (OR 3.16 [1.05–9.48], p = 0.04) were independent factors of H. pylori eradication failure. The eradication failure rates were 14.4%, 7.8%, 7.1%, and 3.1% for the females with age‐CCI ≥2, females with age‐CCI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriMaleHumansFemaleAnti-Bacterial AgentsRetrospective StudiesProton Pump InhibitorsDrug Therapy, CombinationRisk FactorsTreatment OutcomeClarithromycinAmoxicillin

Stichwörter der Autor:innen

helicobacter pyloriage adjusted Charlson comorbidity indexpost-treatment testingreal-world evidencesex

Substanzen

Anti-Bacterial AgentsProton Pump InhibitorsClarithromycinAmoxicillin

Autor:innen und Institutionen

  • Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan.

ORCID-Profile: Chun-Te Lee, Wei-Lun Chang, Bor-Shyang Sheu, Hsiu-Chi Cheng

Förderung

  • Ministry of Health and Welfare
  • National Science and Technology Council

Zitieren

APA

Lee, C. T., Wu, C. T., Chang, W. L., Yang, E. H., Hsieh, M. T., Chen, W. Y., Sheu, B. S., & Cheng, H. C. (2024). The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐ Helicobacter pylori treatment in real‐world clinical practice. Helicobacter, 29(1). https://doi.org/10.1111/hel.13033

Vancouver

Lee CT, Wu CT, Chang WL, Yang EH, Hsieh MT, Chen WY, et al. The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐ Helicobacter pylori treatment in real‐world clinical practice. Helicobacter. 2024;29(1). doi:10.1111/hel.13033

BibTeX
@article{Lee2024,
  author = {Lee, Chun-Te and Wu, Chung-Tai and Chang, Wei-Lun and Yang, Er-Hsiang and Hsieh, Ming-Tsung and Chen, Wei-Ying and Sheu, Bor-Shyang and Cheng, Hsiu-Chi},
  title = {The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐ Helicobacter pylori treatment in real‐world clinical practice},
  journal = {Helicobacter},
  year = {2024},
  volume = {29},
  number = {1},
  doi = {10.1111/hel.13033}
}
Kostenlos starten →